28 April 2020

Postdoc Sam Keating and colleagues from the group of Niels Riksen, theme Vascular damage, revealed Set7 as a key regulator of trained immunity. Trained immunity describes the phenomenon that innate immune cells can develop a long-lasting pro-inflammatory phenotype following brief exposure to a micro-organism or microbial product. Using a combination of pharmacological and genetic approaches, they revealed a critical role for the histone methyltransferase Set7 in trained immunity. They have published their findings in Cell Reports

Trained immunity confers a sustained augmented response of innate immune cells to a secondary challenge, via a process dependent on metabolic and transcriptional reprogramming. Previous research from the department of Internal Medicine showed that trained immunity can protect the host against recurrent infections, but can also contribute the pathophysiology in the context of chronic non-infectious inflammatory disorders, such as atherosclerosis. Because of its previous associations with metabolic and transcriptional memory, as well as the importance of H3 histone lysine 4 monomethylation (H3K4me1) to innate immune memory, they hypothesize that the Set7 methyltransferase has an important role in trained immunity induced by β-glucan. Using pharmacological studies of human primary monocytes, they identify trained immunity-specific immunometabolic pathways regulated by Set7, including a previously unreported H3K4me1-dependent plasticity in the induction of oxidative phosphorylation. This finding was validated in vivo in Set7 knock out mice in collaboration with their colleagues from Melbourne.

The identification of Set7 as a key enzyme in the development of innate immune memory provide a potential pharmacological target to modulate trained immunity.  


  • Want to know more about these subjects? Click on the buttons below for more news.

    Internal Medicine

Related news items


COVID-19 associated coagulopathy - lessons after 1 year

17 May 2021 Jenneke Leentjens, Saskia Middeldorp, and colleagues, published a review on the current knowledge of COVID-19 associated coagulopathy and the role of antithrombotic therapies in the Lancet Haematology. read more

Catecholamines induce trained immunity in monocytes in vitro and in vivo

10 April 2020 Niels Riksen and colleagues contributed data in Circulation Research, to the understanding of pathways driving inflammatory changes in conditions characterized by high catecholamine levels, and proposed that trained immunity underlies the increased cardiovascular event rate in PHEO patients. read more

Dutch National Postdoc award for Siroon Bekkering

29 November 2019 Siroon Bekkering, theme Vascular damage, will use the prize money (€10,000) for her follow-up research into the memory of the innate immune system of patients with cardiovascular diseases. read more

RIMLS PhD grants awarded to eight RIMLS (j)PI's

12 September 2019 Recently, RIMLS held an internal call for Radboudumc junior researcher (PhD) positions. Congratulations for all the awardees and all the best in conducting the research projects. read more

Lowering cholesterol is not enough to reduce hyperactivity of the immune system

14 June 2019 In Cell Metabolism, Siroon Bekkering, theme Vascular damage, and colleagues, provide a novel potential explanation for the residual cardiovascular risk, related to persistent activation of the immune system in patients with hypercholesterolemia who are treated with statins. read more